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Introduction
Cardiac output and cardiac index are key parameters of 
hemodynamics and can be used to evaluate cardiac pump 
function and calculate other parameters like SVR or PVR 
and so on. In patients undergoing cardiac surgery, ther-
modilution using a pulmonary artery catheter (PAC) is 
still the reference gold standard. However, although the 
incidence of complications with the PAC is relatively low, 
the technique is still quite invasive and up to now, there is 
no clear evidence of improved outcomes associated with 
its insertion and use to guide therapy [1–5]. Therefore, 
several less-invasive methods have been proposed [6, 7]. 
Non-invasive methods could be preferable, especially for 
low-risk patients in whom CO monitoring is increasingly 
used nowadays, as non-invasive methods have fewer side 
effects as compared to invasive procedures. One of these 
non-invasive methods is thoracic bioimpedance, which 
analyzes intrabeat variations of transthoracic voltage in 
response to an input high-frequency current; however, 
inconsistent measurements were found in intensive care 
[8, 9, 16].
Recently, a new signal-processing method has been 
developed which is called NICOM. Its signal is based on 
the frequency modulation and phase modulation of the 
output voltage. This advanced bioreactance technology 
improves the signal-to-noise ratio 100-fold. However, the 
accuracy of NICOM has not been confirmed, especially 
when compared with the PAC technique in patients under-
going off-pump coronary artery bypass surgery. Therefore, 
we conducted the following investigation.
Abstract 
Purpose This observational study was designed to evalu-
ate the clinical value of cardiac output (CO) obtained via 
bioreactance (NICOM™) as compared with values of 
CO obtained via thermodilution (using pulmonary artery 
catheter, Vigilance™) and the thoracic bioimpedance 
(BioZ.com™), in patients undergoing off-pump coronary 
artery bypass surgery.
Methods Fifty American Society of Anesthesiologists 
physical status I–III patients, aged 38–81 years, scheduled 
for off-pump coronary artery bypass surgery were enrolled 
in this study. CO data (NCO, BCO, PCO) were recorded 
during the operative period at ten time points after stable 
hemodynamic conditions were achieved.
Results The equation of the relationship between the PCO 
and NCO is PCO = 0.945 × NCO + 0.328 (r = 0.77), and 
that of PCO and BCO is PCO = 0.965 × BCO + 0.729 
(r = 0.63). Furthermore, no statistical difference was 
found between PCO versus NCO (mean (SD): 4.4 (1.1) 
versus 4.4 (0.9), p = 0.431). A significant correlation was 
found between PCO and NCO (r = 0.77, p < 0.001). Cor-
relation was also found between PCO and BCO (r = 0.63, 
p < 0.001).
Conclusions The NICOM device is a safe, convenient, 
and reliable device for measuring continuous non-invasive 
cardiac output and cardiac index, and the trends of change 
in CO during the surgery are similar between NICOM and 
PAC.
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The aim of this study was to evaluate the accuracy of 
CO measured by NICOM in patients undergoing off-pump 
coronary artery bypass surgery, and to compare the results 
with the other two devices: (1) the BioZ.com™ system 
with thoracic bioimpedance, and (2) continuous CO moni-
toring using a PAC with thermodilution.
Patients and methods
Patients undergoing off-pump coronary artery bypass sur-
gery gave their informed consent to the study, which was 
approved by the Ethics Committee of Shanghai Ruijin Hos-
pital (2013/NO.69). Inclusion criteria were  ASA I–III or 
NYHA I–II. A total of 50 patients were recruited for the 
current study with the insertion of PAC. When the patients 
arrived in the operating room, they were connected to 
patient with the NICOM and the BioZ.com placed on the 
each side of the thorax. The CO data and standard hemo-
dynamic data (HR, MAP, SV, and SVI) from all devices 
were record by an observer who was not responsible for the 
patient’s anesthesia. The measurements were free of inter-
ference from surgery or infusion boluses (such as Ringer’s 
solution and succinylated gelatin or vasoactive agents). Pre-
defined measurement points were: T1 = immediate after 
induction of anesthesia (study initiation), T2 = 5 min post-
induction, T3 = 10 min post-induction, T4 = sternotomy, 
T5 = 5 min post-sternotomy, T6 = 10 min post-sternotomy, 
T7 = opening of pericardial, T8 = pericardial closure, 
T9 = sternal closure, T10 = 5 min post-sternal closure.
Statistics
Data are expressed as mean (SD) or median (range) for 
non-normally distributed variables or number and percent-
age as appropriate. CO values obtained from NICOM and 
PAC or BioZ.com and PAC were also using ANOVA. The 
correlation of CO was determined by linear regression. The 
Bland–Altman analysis was used to compare bias and lim-
its of agreement.
A p value of 0.05 was considered as statistically signifi-
cant and all p values were two-tailed. Statistical analysis 
was done by using SPSS for Windows Release 20.0 (SPSS 
Inc., Chicago, IL, USA).
Results
Baseline characteristics for the 50 subjects are indicated in 
Table 1. No statistical difference was found between PCO 
versus NCO (p = 0.431) (Table 2). Figure 1a shows the rela-
tionship of CO data between PAC and NICOM; the equa-
tion of the relationship is PCO = 0.945 × NCO + 0.328 
(r = 0.77). Figure 1b shows the relationship of CO data 
between PAC and Bioz.com; the equation of the rela-
tionship is PCO = 0.965 × BCO + 0.729 (r = 0.63). 
Figure 2 shows the variations in CO for PAC, NICOM and 
BioZ.com in different measurement points during the sur-
gery. PCO and NCO increase at a slower rate from T1 to 
T7 but increase at a faster rate from T8 to T10, whereas 
BCO increases gradually from T1 to T10. The Bland–Alt-
man analysis was used to compare the bias, precision (SD 
of bias), and limits of agreement [bias (1.96 SD)]. The bias 
and limits of agreement of CO between PAC and NICOM 
are depicted in Fig. 3a and the bias and limits of agreement 
of CO between PAC and BioZ.com are depicted in Fig. 3b.
Discussion
Our  study shows that NICOM is convenient and safe in 
a clinical setting, as it only requires the placement of two 
double electrodes on the patient’s thorax. Correlation coef-
ficient of PCO and NCO (r = 0.77) is better than those of 
PCO with BCO (r = 0.63). Although NICOM up to now 
cannot replace the use of PAC, it provides consistent con-
tinuous non-invasive measurements of CO and CI and 
seems to be able to track in real time the trends and the 
change with the time. There is literature that suggests that 
real-time tracking of the trends of change in CO could be 
more important than the ability of the monitor to deliver 
a highly accurate single measurement under stable condi-
tions [10]. In the current study, the trends of change in CO 
during the surgery are similar among the three devices, and 
Table 1  Baseline characteristics of patients (n = 50)
Values are median (range) or number (%)
Sex (M/F) 38/12
Age (year) 65 (38–81)
Height (cm) 166 (154–181)
Weight (kg) 69 (49–86)
Hypertension 29 (58)
Table 2  Comparison of cardiac output (n = 50) between NICOM 
and PAC and between BioZ.com and PAC
Values are mean (SD)
CO cardiac output
* Compared with PAC
NICOM BioZ.com PAC
CO (l/min) 4.4 (0.9) 3.9 (0.7) 4.4 (1.1)
p value* 0.431 <0.001
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the trends by NICOM are closer to PAC than by BioZ.com 
(Fig. 2). From Fig. 3a we can deduce that for values of CO 
between 4 and 6 NICOM and PAC values have a good cor-
relation. For values of CO below 4, NICOM overestimates 
values of CO as compared to PAC. For values of cardiac 
output above 6, NICOM underestimates values of CO as 
compared to PAC. Similarly, from Fig. 3b we can deduce 
that for values of CO between 4 and 6, BioZ.com and PAC 
values have a good correlation. For values of CO below 4, 
BioZ.com overestimates values of CO as compared to PAC. 
For values of CO above 6, BioZ.com underestimates values 
of CO as compared to PAC.
As an invasive hemodynamic monitor, PAC was 
regarded as a gold standard of reference because we have 
no better reference for continuous CO monitoring [11–14]. 
We therefore compared the relationship between non-inva-
sive cardiac output monitor (NICOM) with PAC. In the 
current study, we are still not sure if NICOM can replace 
the PAC as a means to measure CO. A meta-analysis study 
literature also showed that none of the four tested alterna-
tive methods (pulse contour analysis, esophageal Doppler, 
thoracic electrical bioimpedance) achieved agreement with 
PAC [15]. However, considering that the scope of PAC’s 
applicability is limited, and that it also brings a lot of risks 
and complications (e.g., infection) [20], the clinical hemo-
dynamic monitoring is moving towards less invasive or 
even non-invasive methods.
Bioimpedance is based on the fact that the conductiv-
ity of a high-frequency, low-magnitude alternating current 
passed through the thorax changes as blood flow varies 
with each cardiac cycle. These changes can be measured 
using electrodes placed on a patient’s chest and used to 
generate a waveform from which cardiac output can be cal-
culated. However, its accuracy is always in doubt, as the 
technique has its own limitation [16].
Bioreactance is developed out of bioimpedance and 
measures changes in the frequency of the electrical cur-
rents traversing the chest, rather than changes in imped-
ance, potentially making it less sensitive to noise [17, 18]. 
Also, bioreactance-based NICOM has acceptable accuracy 
Fig. 1  Relationship between PCO and NCO (a) and PCO and BCO 
(b). CO cardiac output, NCO cardiac output by NICOM, PCO car-
diac output by PAC, BCO cardiac output by BioZ.com. The continu-
ous line indicates the regression line. The dashed lines indicate 95 % 
confidence intervals
Fig. 2  CO values trend of changes during the surgery. CO cardiac 
output, NCO cardiac output by NICOM, BCO cardiac output by 
BioZ.com, PCO cardiac output by PAC. The horizontal axis repre-
sents measurement points
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in challenging clinical environments [19]. Furthermore, 
one study suggests that NICOM can be clinically valid 
when used in ICU patients [21, 22], but the accuracy of 
NICOM and Bioz.com have not been confirmed, especially 
compared with the PAC technique in patients undergoing 
off-pump coronary artery bypass surgery. This is why we 
compare the three devices to evaluate the accuracy of CO 
measurements in patients undergoing off-pump coronary 
artery bypass surgery. The measurement points in this 
study were defined according to clinical importance of sur-
gical step, as they are also very common in cardiac surgery.
The limitations of the current study are as follows: 
Firstly, all the data for the patient group were collected 
after induction of anesthesia. PAC values before anesthesia 
are unavailable, because we abstained from placing a PAC 
in the patient who is awake so as not to further increase 
discomfort before surgery. Secondly, the study was limited 
only to patients undergoing cardiac surgery and did not 
take into account post-surgical patients in the ICU. Thirdly, 
the current study did not evaluate the ability of the NICOM 
to predict fluid responsiveness.
In conclusion, the NICOM is a safe, convenient device, and 
reliable to continuously and non-invasively monitoring cardiac 
output and cardiac index, and could track the trend of changes 
under dynamic conditions. Although the device cannot replace 
PAC for patients undergoing off-pump coronary artery bypass 
surgery at present stage, it may potentially be used in a wide 
range such as during laparoscopic surgery or for the patients 
with heart diseases undergoing non-cardiac surgery, when 
invasive monitoring is not an option or not desired.
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